• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Triterpenoids
• Triterpenoids

Carbenoxolone disodium (CAS No. 7421-40-1): A Comprehensive Overview of Its Applications and Recent Research Findings

Carbenoxolone disodium, a compound with the chemical formula CAS No. 7421-40-1, has garnered significant attention in the field of pharmaceutical chemistry due to its unique pharmacological properties. This compound, derived from the natural product glycyrrhizin found in licorice root, has been extensively studied for its potential therapeutic applications. The structural complexity and functional versatility of Carbenoxolone disodium make it a subject of interest for researchers exploring novel drug development strategies.

The primary pharmacological mechanism of Carbenoxolone disodium involves its ability to modulate the activity of certain ion channels and receptors in the body. Specifically, it has been shown to interact with the epithelial sodium channels (ENaCs), which play a crucial role in regulating sodium transport across cell membranes. By inhibiting these channels, Carbenoxolone disodium can lead to a reduction in sodium reabsorption, thereby influencing various physiological processes such as blood pressure regulation and fluid balance.

Recent studies have highlighted the potential of Carbenoxolone disodium in treating conditions related to excessive sodium retention. For instance, research published in Journal of Clinical Pharmacology has demonstrated its efficacy in managing conditions like essential hypertension and heart failure. The compound's ability to enhance renal sodium excretion without causing significant side effects makes it a promising candidate for therapeutic intervention.

In addition to its cardiovascular applications, Carbenoxolone disodium has shown promise in other therapeutic areas. Notably, preclinical studies have indicated its potential role in treating neurological disorders by modulating neurotransmitter release and synaptic function. The compound's interaction with specific neurotransmitter systems suggests that it could be beneficial in conditions such as epilepsy and chronic pain syndromes. These findings have prompted further investigation into its neuroprotective properties.

The synthesis and purification of Carbenoxolone disodium are critical aspects that ensure its pharmaceutical efficacy. Advanced synthetic methodologies have been developed to produce high-purity forms of the compound, minimizing impurities that could affect its stability and bioavailability. Techniques such as crystallization and chromatography are commonly employed to achieve the desired purity levels. These advancements in synthetic chemistry have facilitated more rigorous clinical trials and improved our understanding of the compound's pharmacokinetic profile.

One of the most intriguing aspects of Carbenoxolone disodium is its potential for combination therapy with other drugs. Researchers are exploring synergistic effects when Carbenoxolone disodium is used alongside medications for hypertension or heart failure. For example, studies suggest that combining it with ACE inhibitors or diuretics could enhance therapeutic outcomes by targeting multiple pathways involved in cardiovascular regulation. Such combination therapies could offer more comprehensive management options for patients with complex medical conditions.

The regulatory landscape for Carbenoxolone disodium has evolved significantly over the years, reflecting growing interest in its therapeutic potential. Regulatory agencies such as the FDA and EMA have reviewed various formulations and dosages, ensuring that they meet stringent safety and efficacy standards. The approval process involves extensive preclinical and clinical trials to evaluate the compound's benefits and risks. These regulatory milestones underscore the growing recognition of Carbenoxolone disodium as a viable therapeutic option.

Future research directions for Carbenoxolone disodium include exploring its role in personalized medicine. By analyzing genetic markers and individual patient profiles, researchers aim to identify subpopulations that may benefit most from this compound. Personalized treatment approaches could optimize therapeutic outcomes while minimizing adverse effects, representing a significant advancement in patient care.

The industrial production of Carbenoxolone disodium has also seen notable advancements, with manufacturers adopting sustainable practices to minimize environmental impact. Green chemistry principles are being integrated into synthetic processes to reduce waste generation and energy consumption. These efforts align with global initiatives to promote environmentally responsible pharmaceutical manufacturing.

In conclusion, Carbenoxolone disodium (CAS No. 7421-40-1) is a multifaceted compound with diverse therapeutic applications. Its ability to modulate ion channel activity and influence physiological processes makes it valuable in treating conditions ranging from cardiovascular disorders to neurological conditions. Ongoing research continues to uncover new insights into its mechanisms of action and potential applications, reinforcing its significance in modern pharmaceuticals.

• 6277-14-1(Olean-12-en-29-oicacid, 3-(acetyloxy)-11-oxo-, (3b,20b)-)
• 56058-76-5(3-O-Acetyl-28-acetoxy-glycyrrhetinsaeure-methylester)
• 5697-56-3(Carbenoxolone)
• 35959-01-4(1,4-dichloro-2-fluorobenzene)
• 14605-17-5(11-oxo-oleanolic acid acetate)
• 65023-20-3((4aS,6aR,6bS,10S,12aS,14aR,14bR)-Methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4a-carboxylate)
• 52247-86-6(Olean-12-en-29-oicacid, 3-[[[(1R,2S)-2-carboxycyclohexyl]carbonyl]oxy]-11-oxo-, (3b,20b)- (9CI))
• 4827-59-2(Glycyrrhetinyl stearate)
• 18305-96-9(3-(acetyloxy)-11-oxoolean-12-en-29-oic acid)
• 5356-59-2(Olean-12-en-29-oic acid, 11-oxo-3-[(1-oxododecyl)oxy]-, (3β,20β)-)